How quickly does Trestolone Acetate 50mg/ml start working after the first injection?

Trestolone Acetate begins exerting anabolic effects within 24–48 hours of the first injection, owing to rapid ester hydrolysis of the acetate chain in muscle tissue. Free Trestolone enters circulation fast, binds androgen receptors at approximately 2.5× the affinity of testosterone, and initiates AR-mediated transcriptional activity before many longer-ester compounds have even reached peak plasma concentration.

Why does Trestolone Acetate kick in faster than Trestolone Enanthate or Nandrolone Decanoate?

The acetate ester has a half-life of roughly 8 hours, far shorter than enanthate (~4–5 days) or decanoate (~15 days). Shorter esters are hydrolysed more rapidly by tissue esterases, releasing free hormone sooner. Where Nandrolone Decanoate may take 10–14 days to reach functional steady-state plasma levels, Ment 50's acetate ester puts active Trestolone in circulation within the first injection cycle.

How do you know Trestolone Acetate is actually working once you start a cycle?

Three early indicators confirm pharmacological activity: serum estradiol rises within the first week as Trestolone aromatises; endogenous testosterone suppression is typically detectable by day 7 on bloodwork; and subjective training metrics — strength output, intra-workout recovery, pump quality — tend to shift noticeably by days 3–5. These signals, combined with Dragon-Pharma's HPLC-verified 50 mg/ml concentration, confirm compound absorption and receptor engagement.

How should doses be drawn from the 10ml vial using an insulin syringe for accurate micro-dosing?

For daily or twice-daily micro-dose protocols, a 1 ml insulin syringe (100-unit scale) allows precise measurement of 0.25–0.5 ml per draw. Wipe the vial septum with an alcohol swab before each withdrawal, draw slightly more than needed, then expel the air bubble to reach the exact graduation. Each 10 ml vial contains up to 40 draws at 0.25 ml, supporting an extended titration phase without switching vials frequently.

What is the correct storage procedure for Ment 50 after the vial has been opened?

Once punctured, store the vial upright at 2–8 °C (refrigerator temperature) away from light. The multi-dose rubber septum is designed for repeated penetration, but replace your needle after each draw to maintain sterility. Use the vial within 28 days of first opening; discard any remaining solution if you notice particulate matter, cloudiness, or colour change, as these indicate potential contamination or degradation. (2) angle_used

Fast Acting

Dragon-Pharma

Ment 50 50mg/ml 10ml Vial by Dragon-Pharma

Name: Ment 50 50mg/ml 10ml Vial by Dragon-Pharma
Brand: Dragon-Pharma
SKU: INJ-TRES-DRA-50-001
Price: 56.00 EUR
Availability: InStock
Rating: 4.5 (2 reviews)

4.5 (2 reviews)

Dragon-Pharma Ment 50 delivers Trestolone Acetate at a concentration of 50 mg/ml in a 10 ml multi-dose vial — engineered for rapid onset of action, with the short acetate ester enabling measurable anabolic activity within the first 24–48 hours post-injection. Compared to longer-esterified androgens, the acetate chain's brief half-life (approximately 8 hours) means plasma levels rise and fall quickly, giving users faster feedback on efficacy and tighter control over hormonal exposure. Quality is confirmed at batch level: HPLC-quantified potency and LAL endotoxin testing are completed before any vial is released under Dragon-Pharma's GMP-compliant production protocol.

€56.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Rapid anabolic onset: free Trestolone reaches circulation within 24–48 hours via fast acetate ester hydrolysis.
Exceptional androgen receptor affinity — approximately 2.5× that of testosterone — driving strong early-phase transcriptional signalling.
Precise dose control enabled by Dragon-Pharma's HPLC-verified 50 mg/ml fill concentration across every vial.
10 ml multi-dose format supports extended cycles or titration phases without frequent reordering.
LAL endotoxin-tested batches reduce injection-site inflammatory risk from pyrogenic contamination.
Short half-life (~8 hours) allows rapid dose adjustment if side effects emerge, without prolonged systemic exposure.
Structurally distinct 19-nor profile provides a mechanistically different anabolic stimulus compared to testosterone-based injectables.

Phase	dosage	Note
Onset / Titration	25 mg every 12–24 hours (0.5 ml EOD or 0.25 ml daily)	Establish baseline tolerance; short half-life means effects are detectable within 48 hours — adjust based on early estradiol bloodwork.
Active Efficacy Phase	50 mg every 24 hours (1 ml/day) or 25 mg every 12 hours	Split dosing every 12 hours produces more stable plasma peaks and reduces inter-injection troughs, optimising continuous AR engagement.
Advanced / Short-Burst Protocol	75–100 mg/day (split doses) — experienced users only	Higher doses accelerate onset of strength and mass markers but increase estradiol and hematocrit load; bloodwork monitoring is mandatory at this tier.
Cycle Duration	4–6 weeks typical	Acetate ester clears rapidly post-cycle (~2–3 days to sub-threshold levels), enabling a shorter bridge to PCT compared to long-ester Trestolone formulations.

Key takeaways

Expect measurable anabolic onset within 24–48 hours of the first injection.
Schedule injections every 12–24 hours to maintain stable acetate-ester plasma levels.
Monitor serum estradiol by day 7 to confirm active compound absorption.
Verify dose accuracy with Dragon-Pharma's HPLC-confirmed 50 mg/ml concentration.
Store opened vials refrigerated and use within 28 days for full potency.

Trestolone Acetate as a Rapid-Onset Injectable Androgen

Ment 50 is a pharmaceutical-grade injectable formulation in which Trestolone Acetate — a 19-nor androgen structurally distinct from Nandrolone — is suspended at 50 mg/ml to produce fast, measurable anabolic activity within the first 24–48 hours following administration. The acetate ester is the decisive factor here: because ester hydrolysis occurs rapidly in muscle tissue, free Trestolone enters systemic circulation sooner than with propionate or enanthate-esterified androgens, making kick-in time one of the compound's defining clinical and practical characteristics. Users conducting timed-response assessments — tracking nitrogen retention markers or subjective strength indicators — consistently observe early-phase activity that longer-ester compounds cannot match at equivalent molar doses.

How the Acetate Ester Drives Faster Efficacy

Trestolone Acetate carries a half-life of approximately 8 hours, measured from peak post-injection plasma concentration. This short window demands more frequent injection scheduling — typically every 12–24 hours — but it simultaneously delivers a clinical advantage: anabolic signalling through androgen receptor (AR) binding begins within hours of the first dose rather than days. Trestolone binds the androgen receptor with an affinity reported at roughly 2.5× that of testosterone in comparative receptor-binding studies, meaning the early plasma peaks generated by the acetate ester translate into strong AR-mediated transcriptional activity from the outset. Compared to Nandrolone Decanoate, which may require 10–14 days before steady-state plasma concentrations stabilise, Ment 50 reaches its functional anabolic window within the first injection cycle.

Efficacy Markers and On-Cycle Monitoring

Dragon-Pharma's Ment 50 passes HPLC quantification against a certified Trestolone reference standard and LAL endotoxin assay at batch level, ensuring that the declared 50 mg/ml concentration is the actual delivered dose — a prerequisite for reliable onset timing. Each 10 ml vial yields up to 20 individual doses at 0.5 ml per injection, giving users a structured framework for early-phase titration. Monitoring serum estradiol within the first week is advisable: Trestolone aromatises, and rising estradiol serves as a secondary confirmation that the compound is active and absorbed. A serum testosterone suppression signal — typically detectable by day 7 via bloodwork — further validates that the acetate ester is delivering pharmacologically meaningful plasma levels.

Usage

Confirm vial integrity and verify the HPLC batch label on the Dragon-Pharma packaging before drawing — this confirms you are working with the verified 50 mg/ml concentration and not a mislabelled unit.
Warm the vial to body temperature (held in palm for 60 seconds or placed in a warm-water bath at ~37 °C) to reduce solution viscosity and allow smoother draw, particularly important for daily injection schedules.
Swab the rubber septum with a 70 % isopropyl alcohol pad and allow it to dry fully before inserting your draw needle — this is a non-negotiable sterility step for a multi-dose vial used across 4–6 weeks.
Draw your target volume using a fresh needle for each injection; for sub-0.5 ml doses, a 1 ml insulin syringe with 0.01 ml graduations delivers the precision required for onset-titration protocols.
Administer via intramuscular injection into the glute, vastus lateralis or deltoid, rotating sites on consecutive injections to prevent tissue accumulation from the frequent dosing schedule that the acetate ester demands.
Log injection time, dose volume, and any early-onset indicators (strength metrics, pump quality, mood) from day one — the fast-acting nature of Trestolone Acetate makes early data collection meaningful and allows evidence-based dose adjustments within the first week.

Warnings

Contraindications: Ment 50 is contraindicated in individuals with existing prostate carcinoma, breast carcinoma, or severe hepatic impairment. Those with a documented hypersensitivity to 19-nor androgens or to the carrier oil/benzyl alcohol excipients should not use this product. Not indicated for use by females of childbearing potential or individuals under 21 years of age.

Side_Effects: Trestolone Acetate aromatises at a clinically relevant rate; estradiol elevation — with associated water retention, gynecomastia risk, and blood pressure increase — is an expected early-cycle event given the rapid onset profile. Androgenic effects including acne, oily skin, and scalp sensitivity may appear within the first week due to fast receptor activation. Polycythemia (elevated hematocrit) requires periodic monitoring; venous thromboembolism risk increases if hematocrit exceeds 54 %.

Monitoring: Obtain pre-cycle bloodwork including LH, FSH, total testosterone, estradiol, hematocrit, liver enzymes (ALT/AST), and lipid panel. Repeat at day 7–10 of the cycle to confirm compound activity through suppression of gonadotropins and estradiol elevation. Reassess at cycle midpoint and within 2–4 weeks post-cycle. Blood pressure should be self-monitored at least twice weekly throughout.

PCT: Because Trestolone Acetate clears rapidly (plasma levels fall below functional thresholds within approximately 48–72 hours of the last injection), PCT can be initiated earlier than with long-ester compounds. A standard Clomiphene/Tamoxifen protocol initiated 3–4 days post-final injection is appropriate. Aromatase inhibitor use during cycle is commonly necessary given Trestolone's aromatisation rate — taper and discontinue the AI at cycle end before PCT begins.

Frequently asked questions

How quickly does Trestolone Acetate 50mg/ml start working after the first injection?: Trestolone Acetate begins exerting anabolic effects within 24–48 hours of the first injection, owing to rapid ester hydrolysis of the acetate chain in muscle tissue. Free Trestolone enters circulation fast, binds androgen receptors at approximately 2.5× the affinity of testosterone, and initiates AR-mediated transcriptional activity before many longer-ester compounds have even reached peak plasma concentration.
Why does Trestolone Acetate kick in faster than Trestolone Enanthate or Nandrolone Decanoate?: The acetate ester has a half-life of roughly 8 hours, far shorter than enanthate (~4–5 days) or decanoate (~15 days). Shorter esters are hydrolysed more rapidly by tissue esterases, releasing free hormone sooner. Where Nandrolone Decanoate may take 10–14 days to reach functional steady-state plasma levels, Ment 50's acetate ester puts active Trestolone in circulation within the first injection cycle.
How do you know Trestolone Acetate is actually working once you start a cycle?: Three early indicators confirm pharmacological activity: serum estradiol rises within the first week as Trestolone aromatises; endogenous testosterone suppression is typically detectable by day 7 on bloodwork; and subjective training metrics — strength output, intra-workout recovery, pump quality — tend to shift noticeably by days 3–5. These signals, combined with Dragon-Pharma's HPLC-verified 50 mg/ml concentration, confirm compound absorption and receptor engagement.
How should doses be drawn from the 10ml vial using an insulin syringe for accurate micro-dosing?: For daily or twice-daily micro-dose protocols, a 1 ml insulin syringe (100-unit scale) allows precise measurement of 0.25–0.5 ml per draw. Wipe the vial septum with an alcohol swab before each withdrawal, draw slightly more than needed, then expel the air bubble to reach the exact graduation. Each 10 ml vial contains up to 40 draws at 0.25 ml, supporting an extended titration phase without switching vials frequently.
What is the correct storage procedure for Ment 50 after the vial has been opened?: Once punctured, store the vial upright at 2–8 °C (refrigerator temperature) away from light. The multi-dose rubber septum is designed for repeated penetration, but replace your needle after each draw to maintain sterility. Use the vial within 28 days of first opening; discard any remaining solution if you notice particulate matter, cloudiness, or colour change, as these indicate potential contamination or degradation. (2) angle_used

Manufacturer

Dosing accuracy is not a marketing claim at Dragon-Pharma — it is a quantified, batch-specific outcome. For Ment 50, the declared fill of 50 mg Trestolone Acetate per millilitre is arrived at through a process that begins with API assay of the raw trestolone acetate material before formulation, continues through controlled mixing under GMP conditions, and concludes with HPLC quantification of the finished 10 ml vials against a certified reference standard. Fill-volume tolerance across the production run is tracked at batch level, meaning deviation from the stated 10 ml per vial and 50 mg/ml concentration is a recordable nonconformance — not an acceptable manufacturing variance. LAL endotoxin assay data accompanies each released batch, addressing the sterility dimension that fill-weight accuracy alone cannot cover. The result is a vial whose concentration is a measured figure, not a formulation estimate — a distinction that matters directly to users calibrating onset timing and dose-response from the first injection.

Product details

Brand	Dragon-Pharma
Active ingredient	trestolone acetate
Also known as	MENT, Trestolon, Trestolone, Ment 50, Dragon-Pharma MENT
Strength	50 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TRES-DRA-50-001

Reviews

4.5/5

2 reviews

Rating: 5 out of 5 starsDario E.Verified purchaseJul 26, 2026
Most anabolic thing I've touched
10mg/day for 6 weeks as a kickstart to a longer cycle. Strength gains in the first two weeks were genuinely unreal, added 15kg to my deadlift before week 3. Gained 7kg overall, kept 5 after the water settled. Appetite was massive which helped bulking. Sleep was deep and recovery between sessions was noticeably faster. Bloods were a bit all over so ran full PCT after. Not for beginners but this stuff is the real deal
Rating: 4 out of 5 starslinearperiodizationVerified purchaseJun 13, 2026
Powerful but watch the sides
Used at 10mg EOD for 8 weeks. Gains were excellent, put on 6kg and stayed pretty lean doing it. Main gripe is the gyno sensitivity kicked in around week 5, had to add caber and keep AI on hand. Libido went crazy weeks 2-5 then dropped off a bit. Would have been 5 stars if the side profile was a bit cleaner but the product itself is clearly legit based on how my body responded

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

MENT 50mg/ml 10x1ml Ampoules by Imperia Laboratories

Optimal Dosage

MENT 50mg/ml 10x1ml Ampullen by Imperia Laboratories

Imperia Laboratories' MENT 50mg/ml is a sterile injectable solution of Trestolone Acetate at 50 mg per millilitre, presented in ten single-dose 1 ml glass ampoules, specifically formulated to deliver the compound directly into systemic circulation — bypassing the hepatic first-pass metabolism that degrades oral androgens before they reach target tissue. Because Trestolone Acetate administered via intramuscular injection achieves near-complete bioavailability compared to the fraction that survives enteric and hepatic processing in oral formats, each declared milligram translates into functional plasma exposure rather than metabolic waste. Batch release is gated by two mandatory analytical checkpoints: reversed-phase HPLC quantification against a certified Trestolone reference standard, and a Limulus Amebocyte Lysate (LAL) endotoxin assay conducted under current Good Manufacturing Practice (cGMP) conditions.

€58.00

High Concentration

Trestolone Acetate 50mg/ml 10ml Vial by Magnus Pharmaceuticals

Magnus Pharmaceuticals Trestolone Acetate is a high-concentration injectable androgenic compound delivering 50 mg of active Trestolone Acetate per millilitre across a 10 ml multi-dose vial, engineered around a short acetate ester that makes injection scheduling — particularly the time of day and day-of-week placement — a critical performance variable. Because free Trestolone reaches peak plasma concentrations within hours of administration, aligning injections with training windows and circadian hormone rhythms allows users to extract maximum anabolic output from each dose. Quality control is governed by the following sequence: third-party LAL endotoxin testing on every raw-material lot, reverse-phase HPLC potency verification against a certified reference standard, and GMP-classified fill-and-finish to confirm sterility before batch release.

€45.00

Purity Tested

Ment 100mg/ml 10ml Vial by Master Pharma

Master Pharma Ment delivers Trestolone Acetate at 100mg/ml — the highest concentration in this product group — across a 10ml multi-dose vial engineered for athletes who build their training blocks around structured anabolic cycles. Because Trestolone Acetate's short acetate ester supports rapid plasma accumulation, training volume and intensity can be periodized to match the compound's concentration curve from week one. Batch release is conditional on two analytical gates: reversed-phase HPLC potency verification against a certified Trestolone reference standard, and LAL endotoxin clearance — both results documented on the lot-specific Certificate of Analysis.

€48.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00